花园生物11月20日获融资买入2419.56万元，融资余额5.47亿元

Core Insights - Garden Biologics experienced a decline of 2.73% in stock price on November 20, with a trading volume of 164 million yuan [1] - The company reported a financing buy-in amount of 24.2 million yuan and a net financing buy of 1.3 million yuan on the same day [1][2] - As of November 20, the total financing and securities lending balance for Garden Biologics was 548 million yuan, with a financing balance of 547 million yuan, representing 7.26% of the circulating market value [1] Financing and Securities Lending - On November 20, the financing buy-in for Garden Biologics was 24.2 million yuan, with a financing balance of 547 million yuan, which is below the 10% percentile level over the past year [1] - The company repaid 6,900 shares in securities lending and sold 29,300 shares, with a selling amount of 406,400 yuan [1] - The securities lending balance was 773,900 yuan, which is above the 60% percentile level over the past year, indicating a relatively high position [1] Company Overview - Garden Biologics, established on December 18, 2000, and listed on October 9, 2014, is located in Jinhua City, Zhejiang Province [1] - The company's main business focuses on developing, producing, and selling products related to a complete vitamin D3 industry chain [1] - The revenue composition includes vitamin products (47.41%), pharmaceuticals (30.22%), lanolin and derivatives (20.93%), and other minor segments [1] Financial Performance - For the period from January to September 2025, Garden Biologics reported a revenue of 936 million yuan, a slight decrease of 0.20% year-on-year [2] - The net profit attributable to the parent company was 234 million yuan, reflecting a year-on-year decrease of 3.07% [2] Shareholder Information - As of November 10, the number of shareholders for Garden Biologics was 29,100, an increase of 2.11% from the previous period [2] - The average circulating shares per person decreased by 2.06% to 18,378 shares [2] - Cumulatively, the company has distributed 446 million yuan in dividends since its A-share listing, with 178 million yuan distributed over the past three years [3]